• Nenhum resultado encontrado

[PDF] Top 20 Results of CHOP chemotherapy for diffuse large B-cell lymphoma

Has 10000 "Results of CHOP chemotherapy for diffuse large B-cell lymphoma" found on our website. Below are the top 20 most common "Results of CHOP chemotherapy for diffuse large B-cell lymphoma".

Results of CHOP chemotherapy for diffuse large B-cell lymphoma

Results of CHOP chemotherapy for diffuse large B-cell lymphoma

... those of populations from developed countries ...addition of other drugs like VePesid (VP-16) and methotrexate, or with increased doses and/or reduced cycle ...evaluation of these regimens, espe- ... See full document

8

Chronic Inflammation-Related Diffuse Large B-Cell Lymphoma Around the Area of Thoracotomy After Decortication

Chronic Inflammation-Related Diffuse Large B-Cell Lymphoma Around the Area of Thoracotomy After Decortication

... round cell tumor indicating Ewing/PNET or a tumor originated from ...value of 5.5 were seen on FDG-PET/CT images. In the light of all these findings, the case was considered as a primary thorax wall ... See full document

3

PRIMARY CUTANEOUS LARGE B CELL LYMPHOMA OF THIGH: A CASE REPORT

PRIMARY CUTANEOUS LARGE B CELL LYMPHOMA OF THIGH: A CASE REPORT

... cutaneous B-cell lymphomas are a heterogeneous group of rare clonal B- cell lymphoproliferative disorders with distinct clinicopathological features compared with nodal ...cutaneous ... See full document

3

Rev. Hosp. Clin.  vol.57 número5

Rev. Hosp. Clin. vol.57 número5

... Primary lymphoma of the liver is an extremely rare entity. A case of anaplastic large B-cell (both CD-20 and lambda positive) non-Hodgkin’s lymphoma that was confined to ... See full document

6

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.

Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.

... other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle ... See full document

12

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in the Elderly: A Matched Case-Control Analysis.

... by chemotherapy, the first-line treatment regimen is of vital impor- ...advantages of EPOCH over CHOP appear to be significant in EBV-positive cases, but with a conclusion drawn from only 3 ... See full document

11

Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.

Immunohistochemical and molecular characteristics with prognostic significance in diffuse large B-cell lymphoma.

... Interphase FISH analysis was performed on 3- m m TMA tissue sections using commercial dual-color break-apart probes (Abbott Molecular, Des Plaines, IL, USA), according to previously described methods [34,35]. Samples ... See full document

9

In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.

In-vivo biodistribution and safety of 99mTc-LLP2A-HYNIC in canine non-Hodgkin lymphoma.

... Imaging of dogs affected with ...occurring lymphoma were imaged using the above protocol. Three dogs had B-cell lymphoma and 2 dogs had T-cell ...evaluation of fine needle ... See full document

10

Sao Paulo Med. J.  vol.128 número1

Sao Paulo Med. J. vol.128 número1

... Beitler B, Chamone ...células B em uma instituição brasi- leira [The use of the international prognostic index in a Brazilian institution for patients suffering from diffuse large ... See full document

4

J. Appl. Oral Sci.  vol.17 número3

J. Appl. Oral Sci. vol.17 número3

... were diffuse large B-cell lymphoma (DLBCL, N=17); plasmablastic lymphoma of the oral mucosa type (PBLOMT, N=11); Burkitt lymphoma (BL, N=15); extranodal marginal ... See full document

6

Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).

Comparative gene expression profiling identifies common molecular signatures of NF-κB activation in canine and human diffuse large B cell lymphoma (DLBCL).

... The results in this study also support observations made by Gaurnier-Hausser et al in which canonical NF-kappa B activity was evaluated by electrophoretic mobility shift assays and immunoblot analyses, and ... See full document

17

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.

Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas.

... model of the DLBCL subtype featuring the CLTC-ALK translocation and indicate that growth of CLTC-ALK positive DLBCL is dependent on ALK ...trials of ALK inhibitors. The incorporation of ALK ... See full document

11

Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?

Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?

... behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical ... See full document

10

Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer.

Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer.

... time of the analyses described in this paper, our data on lymphatic malignancies were not classified according to the InterLymph classification ...classification of the cases corresponds to the InterLymph ... See full document

14

Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.

Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines.

... up-regulation of DR5 by Resveratrol treatment does give an added attractive target to induce more potent apoptosis without causing toxicity by using combination treatment with sub-toxic doses of Resveratrol ... See full document

12

BIOLOGICAL PREDICTORS OF SURVIVAL IN LYMPHOMA AND MECHANISMS UNDERLYING FOLLICULAR LYMPHOMA TRANSFORMATION INTO DIFFUSE LARGE B CELL LYMPHOMA

BIOLOGICAL PREDICTORS OF SURVIVAL IN LYMPHOMA AND MECHANISMS UNDERLYING FOLLICULAR LYMPHOMA TRANSFORMATION INTO DIFFUSE LARGE B CELL LYMPHOMA

... consisting of multi-agent chemotherapy (bleomycin, cisplatin, etoposide, doxorubicin, cyclophosphamide, vincristine and prednisone) followed by involved field irradiation to sites of original nodal ... See full document

504

Clinicopathologic analysis of localized nasal/paranasal diffuse large B-cell lymphoma.

Clinicopathologic analysis of localized nasal/paranasal diffuse large B-cell lymphoma.

... Diffuse large B-cell lymphoma (DLBCL) comprises 2 molecularly distinct subgroups of non-germinal center B-cell-like (non- GCB) and germinal center ... See full document

10

J. Bras. Patol. Med. Lab.  vol.43 número5

J. Bras. Patol. Med. Lab. vol.43 número5

... was diffuse large B-cell ...consisted of dexamethasone, cyclophosphamide, vincristine, etoposide, carboplatin, adriamycin, and ...cycles of chemotherapy, she unfortunately ... See full document

4

Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma: A Single Portuguese Center Experience

Twenty Years of Autologous Stem Cell Transplantation in Diffuse Large B-Cell Lymphoma: A Single Portuguese Center Experience

... CR with first line standard immunochemotherapy is considered poor prognostic characteristic. However in our series it did not have a relevant impact in the outcome if the patient achieved CR with second line ... See full document

5

Primary Extranodal Non-Hodgkin Lymphoma of the Head and Neck in Patients with Acquired Immunodeficiency Syndrome: A Clinicopathologic Study of 24 Patients in a Single Hospital of Infectious Diseases in Argentina.

Primary Extranodal Non-Hodgkin Lymphoma of the Head and Neck in Patients with Acquired Immunodeficiency Syndrome: A Clinicopathologic Study of 24 Patients in a Single Hospital of Infectious Diseases in Argentina.

... Non-Hodgkin lymphoma (NHL) is an acquired immunodefi- ciency syndrome (AIDS)-defining neoplasm that is mostly a high-grade B-cell ...teristic of extranodal involvement as the clinical ... See full document

6

Show all 10000 documents...